Company intelligence / Profile preview
NOxy Health Products
San Mateo, California, USAnoxyhp.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Preclinical
01
Overview
NOxy Health Products has developed a novel nitric oxide-releasing foam designed to address limitations of current nitric oxide delivery systems for chronic wound care. The company’s lead program is entering first-in-human trials and aims to demonstrate safety and efficacy in chronic wound healing. Early non-clinical data support the platform’s potential as a breakthrough solution
- Therapeutic areas
- OtherEndocrinologyDermatology
- Modalities
- Small molecule (nitric oxide-based)Device (NO-releasing foam technology)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Investors from skilled nursing facilities are noted as strategic partners supporting commercialization strategyNo major pharma partnerships disclosed
Beyond the preview
Go deeper on NOxy Health Products.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NOxy Health Products.